In print today! Our JACC Journals Scientific Statement on #HFpEF: diagnosis, mechanisms and treatment! Kudos to this amazing team: Barry Borlaug Jennifer Ho Sanjiv Shah Sanjiv J. Shah, MD! jacc.org/doi/abs/10.101… Johns Hopkins Medicine Johns Hopkins Cardiology American College of Cardiology Maryland Chapter, American College of Cardiology

MAINTENANT 🔴 Le congrès #ParisECHO touche à sa fin, nous vous attendons dans l’amphithéâtre Bordeaux pour clôturer ensemble cette édition 2023 ! 🗓️ Vendredi 2 juin 🕑 17:00 - 17:30

🌟Obstructive HCM ✨Medio-ventricular dynamic obstruction After 3rd slide - Valsalva maneuver: From 10mmHg to >70mmHg medio-ventricular with no gradient in LVOT ✅ - 😳Look at Ao valve M-mode during maneuver 🔆 #echofirst #cardiotwitter Nicolas Merke Vladyslav Kavalerchyk 🇺🇦

A new evidence-based echocardiographic approach to predict cardiovascular events and myocardial fibrosis in mitral valve prolapse: The STAMP algorithm☆ doi.org/10.1016/j.acvd…

1/ 🚨 NEW #5Pearls on HFpEF! HFpEF is: - Clinical syndrome of heart failure w/ EF 50%+ - ☂️ term | Heterogeneous disease  HFpEF is NOT: - Classic high BP, causing stiff ventricles 🖥️ :coreimpodcast.com/2024/06/05/hfp… ACP CME: bit.ly/CIMCME Sponsor:  coreimpodcast.com/Freed

Most viewed in the last 7 days from JAMA Cardiology: Study examines the effects of cardiac myosin inhibition with mavacamten in patients with HFpEF with left ventricular ejection fraction of 60% or greater. ja.ma/4gRPxSL

Session au top sur l’imagerie multimodale dans les cardiomyopathies aux #JESFC Un plaisir de modérer cette session avec Diala Khraiche 3 intervenants de la Filiale Echo : Patricia Réant, nicolas Piriou et Olivier Lairez piriou nicolas Lairez SFC - Société Française de Cardiologie cardio-online 🫀 #Cardio

#JESFC Thérapeutique du futur: doit-on traiter les patients présentant un retentissement aortique serré et asymptomatique? Que nous disent les études ? Beaucoup de contenus sont déjà disponibles et aussi le replay de cette session cardio-online.fr/Congres/Journe…

cardio-online.fr/Videos/Les-Ent…

NOUVEAU CAS CLINIQUE : Un rétrécissement aortique et une cardiomyopathie hypertrophique obstructive : une association complexe. Lien : echowebline.com/cas-cliniques/…

NOUVEAU CAS CLINIQUE : Une CMH obstructive. Lien : echowebline.com/cas-cliniques/…

Let's not forget OMI. annemergmed.com/article/S0196-…

NOUVEAU CAS CLINIQUE : PET-MRI, ready for clinical use ?. Lien : echowebline.com/cas-cliniques/…

🚨 Catch Us2.ai on the Road! 🚨 We’re excited to be at #ParisEcho 2025, happening 11–13 𝐉𝐮𝐧𝐞 at the 𝘗𝘢𝘭𝘢𝘪𝘴 𝘥𝘦𝘴 𝘊𝘰𝘯𝘨𝘳è𝘴, Paris 🇫🇷. Join us for 𝐥𝐢𝐯𝐞 𝐬𝐜𝐚𝐧𝐧𝐢𝐧𝐠 and get a firsthand look at our cutting-edge AI technology that’s

Distinguishing athlete’s heart from #cardiomyopathy? 🫀 ✅ GLS & RV strain usually preserved in athletes ⚠️ ⬇️GLS or RV strain = 🚩 for HCM/ARVC 🧠 LA strain, morphologic/TDI + #CMR can help 📎: jacc.org/doi/10.1016/j.… #ACCAthleticHeart #EchoFirst #JACCIMG #SportsCardio #cvHCM

#ESC2025 starts with New Guideline Review!! EACVI President American College of Cardiology European Society of Cardiology European Society of Cardiology Journals. VHD guidelines was first! See: bit.ly/2025VHDGuide-E…

🧵ESC 2025 Guidelines on Myocarditis & Pericarditis #Cardiology #MedEd #ESCCongress #CardioEd Bettina Heidecker #myocarditis #Pericarditis 🩺New unified approach: both conditions seen as a spectrum of inflammatory myocardial–pericardial syndrome (IMPS).

Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: NEJM 🥸 Mavacamten is a no go for non-obstructive HOCM 😱Summary 👇👇👇